More Business Briefs
- Business briefs: Pfizer, Novartis, Boehringer Ingelheim, Elsevier
- Business Briefs: inVentiv; Mylan; Royalty Pharma; Pfizer; Edelman
- Business briefs: Actavis, Bayer, Oramed, Elan
- Business briefs: Pfizer, BMS, CMS, Sanofi
- Business briefs: Bayer, FDA, Ranbaxy
CBS Evening News and BusinessWeek collaborated on a series titled Doctors under the influence?, looking at whether speaking and consulting fees paid by pharmas to docs bias their decision-making. The June 26 CBS piece cited a University of Quebec study that calculated pharma payments to doctors are at $57 billion a year.